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IntRoDUCtIon
Depression contributing to cardiovascular dis-
ease is a major clinical problem both due to 
its frequent occurrence and serious health ef-
fects. A wide variety of studies have confirmed 
a strong relationship between depressive disor-
ders and the risk of development and unfavour-
able course of coronary artery disease (CAD) and 
myocardial infarction [1, 2]. The risk of CAD and 
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Summary
Introduction: Studies confirm a strong relationship between depression and coronary artery disease (CAD). 
Despite this, depressive disorders in CAD patients are often misdiagnosed and under-treated.
Aim: 1) to investigate whether CAD patients qualified for percutanous coronary interventions (PCI) de-
velop any specific type of depressive disorders; 2) to assess the depressive symptoms in CAD patients af-
ter the successful PCI.
Subject	and	methods: of 227 CAD patients, qualified for PCI, 156 with optimal PCI result were includ-
ed. Patients were assessed with the Hamilton Depression Rating Scale (HDRS), Beck Depression Inventory 
(BDI), Rosenberg Self-Esteem Scale (RS), Hopelessness Scale (HS), Automatic Thoughts Questionnaire (ATQ) 
one day before and 1 month after PCI.
Results: The results were compared to the group of 49 depressed patients without CAD, treated in psy-
chiatric setting (group III). Depressive symptoms, observed at the baseline in 75 patients (48.1% – group 
I) were of mild or moderate severity with the prevalence of somatic complains. A comparison between 
group I and group III revealed different characteristics of depressive symptomatology, while the severity 
of depression was comparable. One month after the PCI, depressive symptoms persisted in 33 subjects, 
in whom at the baseline BDI, ATQ and HS scores were significantly higher as compared to 42 patients in 
whom depressive symptoms resolved.
Conclusions: Successful PCI is not a sufficient determinant for the improvement of depressive symptoms. 
Diagnosis of depression in CAD patients needs a special attention, because of a specific clinical picture and 
tendency to persistence.
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cardiac death seems to be correlated to the sever-
ity of depression [3, 4, 5, ]. Depressive disorders 
occur more frequently in CAD patients than in 
the general population. Transient and short-term 
depressive symptoms are observed in more than 
half of the patients during the first few days af-
ter the myocardial infarction. Moreover, in 1–
22% of cases DSM major depression criteria are 
fulfilled [7, 8, 9].
The association between depression and CAD 
is not merely coincidental, but proved psycho-
logical (isolation, lack of social support), behav-
ioural (lifestyle, compliance) and pathophysio-
logical (stress axis hyperactivity, adrenergic acti-
vation, altered autonomic activity, platelet dys-
function, immunological changes) mechanisms 
underlie this comorbidity.
The comorbidity of depressive disorders and 
CAD increases the risk of major cardiac episodes, 
illness’ severity, longer-term disability, worse 
physical capacity and about 50% greater risk of 
cardiac mortality [, 10, 11, 12, 13, 14, 15]. Subjec-
tive quality of life is also diminished.
Despite these important clinical implications, 
depressive disorders in CAD patients are rare-
ly well-diagnosed or adequately treated. It is es-
timated that only 25% of depressive disorders 
comorbid with CAD are recognized [1]. Usu-
ally, mild or moderate levels of depression with 
nonspecific clinical symptomatology and a pre-
dominance of physical complaints may be the 
reason for misinterpretation of depressive psy-
chopathology as signs of a poor physical state or 
drug induced side-effects.
The aims of our study were: 1) to investigate 
whether CAD patients qualified for PCI devel-
op any specific type of depressive symptomatol-
ogy; 2) to assess the depressive symptoms after 
the successful PCI in CAD patients.
SUBJeCtS	AnD	MetHoDS
Subjects
227 patients diagnosed with stable CAD (CCS II-
III), with no previous history of PCI or coronary 
artery by-pass grafting (CABG), qualified for an 
elective PCI (balloon angioplasty, angioplasty 
with stent implantation, rotational atherecto-
my) were enrolled in the study. Angiograph-
ic and clinical successful outcome of interven-
tion, as well as lack of recurrent symptoms of 
ischemia during the four weeks following the in-
tervention, made the patient eligible for further 
analysis. PCIs were performed according to gen-
erally accepted standards of practice. The opera-
tor’s task was to achieve an optimal result for the 
procedure, which was defined as final diameter 
stenosis < 30% (estimated in quantitative coro-
nary angiography) without a high grade of dis-
section with good coronary flow (TIMI 3). Stents 
were used for an abrupt or threatened vessel clo-
sure, as well as in the case of a suboptimal result 
of balloon angioplasty (final diameter stenosis < 
20% was recognized as an optimal result of stent 
implantation). The operators were allowed to use 
intravascular ultrasonography for additional op-
timalization of intervention. The clinically suc-
cessful PCI was defined as an angiographical-
ly effective procedure without serious compli-
cations, in conjunction with a reduction of clin-
ical symptoms. Patients with one vessel disease, 
as well as those with multivessel disease were 
included in the study. PCIs were performed ei-
ther as non-staged or staged procedures, during 
one hospital stay.
Symptoms of angina were assessed before 
PCI and four weeks after the intervention using 
the Canadian Cardiovascular Society classifica-
tion (CCS) [17]. In the instances of atypical chest 
pain after PCI, evaluation of myocardial ischae-
mia was based on the results of the exercise test. 
Only patients with complete functional revascu-
larization were included.
Methods
The psychopathological status of the patients 
was assessed: one day before, one month,  
months, 12 months after the PCI intervention. 
In this paper, the subanalysis of results obtained 
at the first and second examinations is present-
ed. The following instruments were adminis-
tered: structured medical history, 21-item Ham-
ilton Depression Rating Scale (HDRS21), Beck De-
pression Inventory (BDI), Rosenberg Self-Esteem 
Scale (RS), Beck Hopelessness Scale (HS), and 
Automatic Thoughts Questionnaire (ATQ) [18, 
19, 20, 21, 22]. A patient was classified as being 
depressed according to the results of the clinical 
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examination and BDI, HDRS scores. Since the 
validity of those scales (especially HDRS) may be 
problematic in patients with concurrent somatic 
illnesses, it has been suggested by many authors 
that the higher cut-off scoring should be cho-
sen for better diagnostic accuracy [23, 24]. In this 
study it was accepted that a score > 11 points in 
BDI indicate the presence of depression.
Additionally, the mean BDI, BDI 13 (cognitive 
– affective subscale) and BDI 14–21 (somatic sub-
scale of BDI) [25], scores of CAD patients were 
compared with a group of 49 patients with re-
current depressive disorder treated at the outpa-
tient unit of the Department of Psychiatry, Col-
legium Medicum UJ, and fulfilling ICD–10 cri-
teria for a mild or moderate depressive episode 
(Group III). The patients from group III were free 
of severe somatic disorders, including CAD.
The distribution of the age of patients was 
examined with descriptive statistics (median, 
mean, standard deviation) and boxplots. If the 
normality and equality of variance assumptions 
were present, the difference in the mean age in 
the two groups was tested using a t-test. If the 
assumptions were not met, a non-parametric 
test was used (Wilcoxon rank-sum test). Statisti-
cal analysis of psychological tests was based on 
a comparison of mean results. Before conduct-
ing statistical analysis, normal distribution was 
checked (Shapiro-Wilk test). Mean scores, results 
and standard deviations of BDI, BDI 13, BDI 14–
24, HS, RS, ATQ, HDRS were compared (Mann 
Whitney U test, Wilcoxon test). Spearman’s rank 
correlation coefficients were calculated to permit 
examination of the association between cardio-
vascular function impairment (CCS criteria) and 
severity of depression. All statistical tests were 
two-sided. A p value of < 0.05 was considered 
statistically significant.
ReSULtS
Of 227 patients enrolled, 71 were excluded be-
cause of: suboptimal result of PCI (n=31); hospi-
talizations due to non-cardiological reasons dur-
ing the one-year follow-up (n=14), compliance 
failure (n=2). The final group consisted of 15 
patients (39–71 year-old; mean age: 55.05±8.25) 
including: 135 males (8.5%) and 21 females 
(13.5%) who were followed up for one year. 115 
subjects (73.3%) had a previous history of car-
diac infarction. According to the CAD risk fac-
tors: 108 of patients (9%) had hyperlipidemia, 
97 (2%) were diagnosed with hypertension and 
19 (12%) with diabetes II type. 70 patients (45%) 
were smokers.
In the entire group of patients (n=15) there 
were no significant correlations between angi-
na symptoms impairment (CCS criteria) and se-
verity of depression, assessed with HDRS or BDI 
in; (Spearman rank correlation, HDRSvsCCS 
r=0.25; BDIvsCCS r=0.27, p- NS). The presence 
or absence of depressive symptomatology dur-
ing the first examination was the defining cri-
terion for group I (n=75, 48.1%) – patients de-
pressed before PCI and II (n=81, 51.9%) – pa-
tients without the symptoms of depression pri-
or to intervention.
The severity of depression assessed one day 
before PCI in group I was mild or moderate (20.2 
±5.7 points in BDI, 1.0 ± 5.2 points in HDRS), 
with a prevalence of somatic symptoms (BDI 
13 = 9.77 ± 4.; BDI 14–21 = 10.38 ± 3.0). The 
characteristic of thinking style, i.e. negative auto-
matic thoughts, low self-esteem, and feelings of 
hopelessness, were significantly higher in group 
I than in group II (Tab.1).
Qualitative analysis of the severity of de-
pressive symptoms, based on BDI items, per-
table1.	Mean and standard deviation of BDI, HS, RS, ATQ scores in group I and II at first examination point
Group I (n=75) Group II (n=81) Group I vs. II* (p value)
HDRS 16.06 ± 5.2  4.46 ± 2.71 p< 0.001
BDI 20.2 ±5.7  7.0 ± 3.2 p< 0.001
HS  9.8 ± 4.6  4.2± 2.8 p< 0.001
RS 70.4 ± 14.6 85.0 ± 10.5 p< 0.001
ATQ 64.1 ± 14.3 49.2 ± 12.5 p< 0.001
*Mann-Whitney U test
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formed on group I revealed the highest rating 
(mean score >1.0) in the following items: 2 (Pes-
simism), 12 (Social withdrawal), 13 (Indecisive-
ness), 15 (Retardation), 1 (Insomnia), 17 (Fati-
gability), 19 (Loss of Weight), 20 (Somatic pre-
occupation) and 21 (Low level of energy). The 
lowest rated (mean < 0.5) were: 5 (Guilt),  (Ex-
pectation of punishment), 7 (Dislike of self) and 
9 (Suicidal ideation).
A comparison between group I and group III 
revealed different characteristics of depressive 
symptomatology, while the severity of depres-
sion, as measured by BDI, was comparable. There 
was a predominance of somatic complaints (BDI 
14–21 subscale) in group I, while patients from 
group III presented more severe affective-cogni-
tive symptoms, reflected by significantly higher 
BDI 1–13 subscale scoring (Tab.2).
One month after the PCI procedure (second 
examination), depressive symptoms were ob-
served in 45 patients (28.9%). Depressive symp-
toms were still present in 33 subjects from group 
I, while in the rest of group I (n=42) spontane-
ous improvement was observed. Moreover, in 
group II (patients free of depressive symptoms 
a day before PCI) twelve patients developed de-
pressive symptomatology during the 4 weeks af-
ter the procedure. Based on these findings, the 
following subgroups were identified for further 
analysis: Ia (n=33) – patients with depressive 
symptoms persisting one month, Ib (n=42) – pa-
tients in whom depressive symptoms abated, IIa 
(n=12) – patients without depression before PCI 
in whom depressive symptoms developed prior 
to the second examination, IIb (n=9) – patients 
without depression both before and one month 
after PCI. The aim of further analysis was to in-
vestigate the presence of qualitative or quantita-
tive features predicting a high risk of depression 
and its persistence after the PCI.
At the first examination (before PCI), more se-
vere both affective-cognitive (BDI 13) and somat-
ic symptoms (BDI 14–21) of the depressive syn-
drome were detected in subgroup Ia in compari-
son with subgroup Ib. Moreover, in subgroup Ia, 
a significantly higher frequency of negative au-
tomatic thoughts (ATQ) and more pronounced 
hopelessness (HS) were observed. A comparison 
of RS scores revealed no statistically significant 
difference between subgroups Ia and Ib (Tab.3).
The qualitative comparison of severity of de-
pressive symptoms measured by BDI items 
showed that symptoms included in items: 2 (Pes-
simism ), 7 (Dislike of self), 8 (Self Accusation), 
9 (Suicidal ideation), 11 (Irritability), 15 (Retar-
dation), 1 (Insomnia), and 19 (Loss of Weight), 
table	2.	Comparison of mean BDI and BDI subscales rates between group I and III (Mann Whitney test) 
Group I (n=75) Group III (n=49) Group I vs. III (p value)
BDI 20.2 ±5.7 21.1 ±6.5 NS
BDI 13  9.8 ± 4.6 13.9 ± 4.0 p< 0.001
BDI 14–21 10.4 ± 3.0  7.2 ± 3.2 p< 0.001
table	3.	Mean and standard deviation of BDI, HS, RS, ATQ scores in subgroup Ia and Ib at first examination point.
Scores at first examination point Subgroup Ia (n=33) Subgroup Ib (n=42) Subgroup Ia vs. Ib* (p value)
HDRS 17.8 ± 5.18 14.69 ± 4.85 p<0.05
BDI 22.5± 5.8 18.3± 4.9 p<0.05
BDI 13 11.2±4.8  8.7±4.2 p<0.05
BDI 14–21 11.4± 2.6  9.6± 3.1 p< 0.05
ATQ 68.1± 15.9 61.0± 12.2 p<0.05
RS 67.2 ± 16.8 73.0± 12.2 NS
HS 11.7± 4.7  8.2± 3.9 p<0.001
*Mann-Whitney U test
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were scored significantly more highly noted in 
subgroup Ia than in subgroup Ib (p<0.05 Mann-
Whitney U test), (Fig. 1).
The comparison of subgroups Ia and Ib showed 
that the tendency towards persistent depressive 
symptomatology at the further follow-up was asso-
ciated with more severe affective-cognitive and so-
matic symptoms, more frequent negative automat-
ic thoughts, and higher levels of hopelessness.
In subgroup IIa, the depressive symptoms be-
fore the intervention (first examination) were 
mild, although more severe than in subgroup IIb, 
and statistically significant differences between 
subgroups was observed in both BDI subscales 
(BDI 13; BDI 14–21). Moreover, the frequency 
of negative automatic thoughts measured with 
ATQ was significantly higher in subgroup IIa. 
There were no significant differences in RS scor-
ing and HS scoring between subgroups IIa and 
IIb (Tab.4).
DISCUSSIon
The present study confirms that non-specific 
depressive symptoms are very common in CAD 
Figure	1. Mean BDI items rating in subgroups: Ia and Ib; comparison between subgroups (Mann-Whitney test; * –
p<0.005)
table	4.	Mean and standard deviation of BDI, HS, RS, ATQ scores in group IIa and IIb at first examination point
scores at first examination point Subgroup IIa (n=12) Subgroup IIb (n=69) Subgroup IIa vs. IIb (p value)
HDRS  6.0±1.27  4.20±2.81 p<0.05
BDI 10.0 ±0.8  6.5±3.2 p<0.05
BDI 1–13  3.7±2.2  2.4±1.7 p<0.05
BDI 14–21  6.3±2.8  4.1±2.8 p<0.05
ATQ 60.7±12.6 47.2±11.4 p<0.05
HS  5.5±3.8  4.0± 2.6 NS
RS 82.5±11.9 85.5±10.3 NS
*Mann-Whitney U test
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patients requiring revascularization. Mild and 
moderate depressive disorders with the preva-
lence of somatic symptoms were observed one 
day before PCI in 48% of the enrolled patients. 
Similarly to a study by Freedland et al [7] apart 
from somatic complaints the most frequent de-
pressive symptoms were: concern about the fu-
ture, loss of interest in other people, difficulties 
with decision-making, sleep disorders, fatigue 
and diminished libido.
One month after successful PCI depressive 
symptoms were still present or newly developed 
in 28.9% of patients. The tendency towards per-
sistent depressive symptomatology , observed 
one month after PCI, was associated with more 
severe affective-cognitive and somatic symptoms 
of the depressive syndrome; more frequent neg-
ative automatic thoughts, and stronger hopeless-
ness. The depressive symptoms in the group of 
patients without depression before PCI in whom 
depressive disorders developed on second ex-
amination, before the intervention were mild, 
although stronger than in the subgroup of pa-
tients who were free of depression during the 
follow-up. These findings confirm the observa-
tion by Hance et al [8] concerning the CAD pa-
tients fulfilling DSM criteria for a major depres-
sion. In the study by Hance, patients with high-
er BDI rating were more likely to have persistent 
depressive symptoms.
These findings indicate that depressive disor-
ders in patients with CAD – even after successful 
intervention – have a tendency to persist or de-
velop, and because of clinical peculiarities, may 
be a source of major diagnostic difficulties. Such 
difficulties are the result of the overlapping of 
“pure” depressive symptoms with signs of acute 
emotional reaction and non-specific signs of so-
matic disease which may be similar one to anoth-
er [2]. For example, symptoms such as: fatigue, 
sleep problems, anorexia, weight change – may 
reflect both mental and somatic pathology.
Several authors have pointed out some differ-
ences between depressed patients with affective 
disorders and patients suffering from somatic 
diseases comorbid with depression. The sever-
ity of depression in patients who have no fami-
ly history of affective disorders and are hospital-
ized in non-psychiatric units is usually less, and 
the risk of its development is the same for both 
sexes [27, 28, 29]. However, although worrying 
about health and future, sleep disorders, and ap-
petite loss are quite common in somatic diseases, 
they are more frequent and more severe in cases 
of concomitant depression [28, 29]. On the other 
hand, worrying associated with severe somatic 
disease and waiting for the operation or any pro-
cedure (e.g. PCI) may induce or exacerbate the 
depression-like symptoms, e.g.: problems with 
concentration, insomnia, isolation, fatigue, ap-
petite loss and anhedonia [30].
The predominance of somatic symptoms in de-
pressed CAD patients may be a result of specif-
ic features of the non-psychiatric medical inter-
view. Patients who have become accustomed to 
being asked only about their somatic complaints 
may be convinced that doctors are not concerned 
about the patients’ emotions, and that only so-
matic signs are important and worth mentioning 
during the interview. This may result in the so-
matization of depressive symptoms.
Many authors [31, 32] have noticed that after 
myocardial infarction patients show low self-es-
teem, low tolerance of frustration, suppressed 
hostility, dependence, passivity, and inability 
to express anger adequately. These non-specif-
ic symptoms were named vital exhaustion syn-
drome by Appels, and found to be negative prog-
nostic factors for CAD patients [33]. It is unclear 
whether vital exhaustion is a separate psycho-
pathological syndrome induced by cardiologi-
cal disease, or a type of depressive disorder. Ac-
cording to current diagnostic criteria for psychi-
atric disorders (DSM IV and ICD–10), diagnosis 
of depression is based on the presence of a re-
quired number of symptoms, but not on their 
chronology. This is why vital exhaustion is prob-
ably synonymous with depression. It seems that 
the replacement of synonyms with one univer-
sal term – depression – may contribute to an eas-
ier diagnostic process, better education, and bet-
ter cooperation between psychiatrists and cardi-
ologists.
ConCLUSIonS
These facts, together with the results of the 
present study, strongly suggest that diagnosis 
of depression in patients suffering from seri-
ous somatic disorders such as CAD needs spe-
cial attention, and should be based on a clini-
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cal examination supported by instruments de-
tecting the severity and predominance of some 
depressive symptoms (BDI and its subcscales, 
HDRS), as well as describing dimensions of de-
pressive thinking like hopelessness (HS) and 
low self-esteem (RS). The common psychological 
and pathophysiological background, and over-
lapping of etiopathogenetic factors, are sugges-
tive of the important role of the psychopatho-
logical symptoms in the treatment and rehabili-
tation of CAD patients. Successful intervention is 
not a sufficient determinant of improvement in 
the mental state. An optimized comprehensive 
approach to CAD patients with concomitant de-
pressive symptoms may require inclusion of psy-
chological intervention, and, in justified cases, 
even psychiatric treatment.
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